2型糖尿病患者药物治疗依从性与结局的关联:一项Meta分析
该Meta分析纳入8项观察性研究(n=318,125),评估2型糖尿病患者药物治疗依从性与心血管疾病、全因死亡及住院风险的关联。依从性差者平均比例为37.8%(95%CI 37.6-38.0)。依从性好(≥80%)较差的患者全因死亡风险RR为0.72(95%CI 0.62-0.82,I²=0%,3项研究),住院风险RR为0.90(95%CI 0.87-0.94,I²=63%,7项研究)。未发现小研究偏倚证据,但作者指出不能排除偏倚作为这些发现的解释。
要点
- 依从性好(≥80%)与较差相比,全因死亡风险RR=0.72(95%CI 0.62-0.82,I²=0%,3项研究)。
- 依从性好(≥80%)与较差相比,住院风险RR=0.90(95%CI 0.87-0.94,I²=63%,7项研究)。
- 仅1项研究报告了依从性与心血管疾病结局的关联,无试验报告依从性相关结局。
核心结论
- 未发现报告依从性相关结局的随机对照试验,提示系统性地未能纳入该信息。
- 现有观察性研究的合并估计提示,2型糖尿病患者良好的药物依从性与全因死亡和住院风险降低相关,但不能排除偏倚作为这些发现的解释。
研究设计与样本
- 检索多个电子数据库从建库至2016年4月27日,纳入报告2型糖尿病成人依从性与心血管疾病、全因死亡或住院结局的随机对照试验、病例对照研究和队列研究。
- 纳入8项观察性研究,总样本量n=318,125;仅5项研究提供了校正估计值。
- 采用随机效应Meta分析计算合并相对危险度(RR),使用GRADE方法评估纳入研究的偏倚风险。
主要发现
- 依从性差者平均比例为37.8%(95%CI 37.6-38.0)。
- 依从性好(≥80%)与依从性差相比,全因死亡风险RR=0.72(95%CI 0.62-0.82,I²=0%,3项研究)。
- 依从性好(≥80%)与依从性差相比,住院风险RR=0.90(95%CI 0.87-0.94,I²=63%,7项研究)。
- 未观察到小研究偏倚证据;仅1项研究报告了依从性与心血管疾病结局的关联。
临床怎么用
- 原文未据此给出推荐。
局限性
- 仅5项研究提供了校正估计值。
- 仅1项研究报告了依从性与心血管疾病结局的关联。
- 未发现报告依从性相关结局的随机对照试验,提示系统性地未能纳入该信息。
- 作者指出不能排除偏倚作为这些发现的解释。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: A previous study suggests an association between poor medication adherence and excess mortality in chronic disease. The purpose of this study was to assess the association between medication adherence and risk of cardiovascular disease (CVD), all-cause mortality, and hospitalization in type 2 diabetes. RESEARCH DESIGN AND METHODS: We conducted an electronic search on many electronic databases from inception to 27 April 2016. We selected randomized controlled trials and case-control and cohort studies reporting on CVD, all-cause mortality, or hospitalization outcomes by adherence in adults with type 2 diabetes. Two reviewers independently screened for eligible studies and extracted outcome data. Pooled relative risks (RRs) were calculated using a random-effects meta-analysis; risk of bias in each of the included studies was assessed using the GRADE approach. RESULTS: Eight observational studies were included (n = 318,125). The mean rate of poor adherence was 37.8% (95% CI 37.6-38.0). Adjusted estimates were provided by five studies only. The RRs of good (≥80%) versus poor adherence to medication were 0.72 (95% CI 0.62-0.82, I2 = 0%, three studies) for all-cause mortality and 0.90 (0.87-0.94, I2 = 63%, seven studies) for hospitalization. No evidence of small study bias was observed. Only one study reported CVD outcomes by adherence. CONCLUSIONS: We identified no trials reporting on outcomes by adherence, suggesting a systematic failure to include this information. Pooled estimates from available observational studies suggest that good medication adherence is associated with reduced risk of all-cause mortality and hospitalization in people with type 2 diabetes, although bias cannot be excluded as an explanation for these findings.
引用
- Khunti K, Seidu S, Kunutsor S, et al. Association Between Adherence to Pharmacotherapy and Outcomes in Type 2 Diabetes: A Meta-analysis. Diabetes Care. 2017. PMID: 28801474. doi:10.2337/dc16-1925
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。